# Optimum Platelet Inhibition After Coronary Bypass Surgery

> **NCT00262275** · NA · COMPLETED · sponsor: **Papworth Hospital NHS Foundation Trust**

## Conditions studied

- Ischemic Heart Disease

## Interventions

- **DRUG:** Aspirin, Clopidogrel

## Key facts

- **NCT ID:** NCT00262275
- **Lead sponsor:** Papworth Hospital NHS Foundation Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2004-07
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2016-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00262275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00262275, "Optimum Platelet Inhibition After Coronary Bypass Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00262275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*